Federal Relations

September 30, 2009

President Obama Marks Midway Point of NIH Recovery Act Awards

Today, at the National Institutes of Health (NIH), President Obama announced that the Administration has released nearly half ($5 billion) of the funding provided the NIH in the American Recovery and Reinvestment Act (ARRA). To date, the University of Washington has drawn roughly $40 million in ARRA NIH awards. President Obama stated that the more

August 21, 2009

New CDC H1N1 Guidance for Universities

Department of Health and Human Services (HHS) Secretary Kathleen Sebelius and Department of Education (ED) Secretary Arne Duncan joined with Dr. Beth Bell, Deputy Director, National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention (CDC), to announce new guidance for Institutions of Higher Education (IHE) to plan for and

July 28, 2009

HHS Recovery Act Funding Available to Expand Health Professions Training

HHS Secretary Kathleen Sebelius today announced the availability of $200 million to support grants, loans, loan repayment, and scholarships to expand the training of health care professionals.  The funds are expected to train approximately 8,000 students and credentialed health professionals by the end of fiscal year 2010.  Today’s funds are part of the $500 million

July 15, 2009

House Democrats Release Health Care Legislation

Yesterday, House Democrats finally unveiled their comprehensive health care overhaul legislation, including details on how they intend to pay for it.  For the most part, the $1 trillion-plus plan would be paid for through a surtax on upper incomes (families with adjusted gross incomes of more than $350,000) and by more than $500 billion in

July 8, 2009

President Obama Nominates New NIH Director

Today, President Barack Obama nominated Francis S. Collins as the new Director of the National Institutes of Health (NIH). Dr. Collins served as Director of the National Human Genome Research Institute (NHGRI) at NIH from 1993-2008. He is a physician-geneticist noted for his discoveries of disease genes and his leadership of the Human Genome Project.

July 7, 2009

NIH Issues New Stem Cell Research Guidelines

Yesterday, July 6th, the National Institutes of Health issued new guidelines for the use of embryonic stem cells in research. The new guidelines reflect feedback received during a public comment period. Several higher education associations have praised NIH for addressing concerns with the initial draft guidelines. SUMMARY: The National Institutes of Health (NIH) is hereby

June 10, 2009

VA Medical and Health Centers to Receive ARRA Funding

President Obama and Vice President Biden today released a plan to create or save more than 600,000 jobs over the next 100 days by accelerating implementation of the American Recovery and Reinvestment Act. The Roadmap to Recovery plan includes a Department of Health and Human Services project to enable 1,129 health centers to expand access

June 8, 2009

Senator Feingold Introduces Bill to Help Displaced Workers

Senator Feingold on Helping Displaced Workers Find Health Care Jobs Wednesday, June 3, 2009 Washington, D.C. – U.S. Senator Russ Feingold introduced legislation today to help displaced workers in communities hit hard by the tough economy retrain for high-demand health care jobs. Feingold’s Community-Based Health Care Retraining Act specifically targets communities that have suffered job

May 28, 2009

AAU Issues Comments on Draft NIH Stem Cell Guidelines

The Association of American Universities (AAU) has provided comment on proposed NIH Stem Cell Guidelines (see below). May 27, 2009 AAU President Robert M. Berdahl yesterday submitted AAU’s comments on proposed guidelines for human embryonic stem cell research funded by the National Institutes of Health (NIH).  The AAU letter praises President Obama’s March 9, 2009

April 29, 2009

Conflict of Interest Rules Proposed for Medical Research

A recent report from the Institute of Medicine recommends that researchers and medical faculty members decline all gifts from medical companies and refuse to publish or present material that is ghostwritten for such companies in order to avoid real or perceive conflicts of interest.   The recommendations also suggest broader reporting requirements of researchers’ ties to

« Previous Page Next Page »